Page 15 - Read Online

Aledo-Serrano et al. J Transl Genet Genom 2021;5:443-55 https://dx.doi.org/10.20517/jtgg.2021.40 Page 453

Contributed to the conception and design of the review: Aledo-Serrano A, Sanchez-Alcudia R, Gil-Nagel A

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Ellis CA, Petrovski S, Berkovic SF. Epilepsy genetics: clinical impacts and biological insights. Lancet Neurol 2020;19:93-100. DOI
PubMed
2. Symonds JD, Zuberi SM, Stewart K, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-
based national cohort. Brain 2019;142:2303-18. DOI PubMed PMC
3. Symonds JD, McTague A. Epilepsy and developmental disorders: next generation sequencing in the clinic. Eur J Paediatr Neurol
2020;24:15-23. DOI PubMed
4. Hebbar M, Mefford HC. Recent advances in epilepsy genomics and genetic testing. F1000Res 2020;9:185. DOI PubMed PMC
5. Kalser J, Cross JH. The epileptic encephalopathy jungle - from Dr West to the concepts of aetiology-related and developmental
encephalopathies. Curr Opin Neurol 2018;31:216-22. DOI PubMed
6. Johnson MR, Shorvon SD. Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait. Epilepsy Behav
2011;22:421-7. DOI PubMed
7. Shankar R, Perera B, Thomas RH. Epilepsy, an orphan disorder within the neurodevelopmental family. J Neurol Neurosurg Psychiatry
2020;91:1245-7. DOI PubMed
8. Striano P, Minassian BA. From genetic testing to precision medicine in epilepsy. Neurotherapeutics 2020;17:609-15. DOI PubMed
PMC
9. Heinzen EL. Somatic variants in epilepsy - advancing gene discovery and disease mechanisms. Curr Opin Genet Dev 2020;65:1-7.
DOI PubMed PMC
10. Jesus-Ribeiro J, Pires LM, Melo JD, et al. Genomic and epigenetic advances in focal cortical dysplasia types I and II: a scoping
review. Front Neurosci 2020;14:580357. DOI PubMed PMC
11. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the
ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-85. DOI PubMed
12. Korff CM, Brunklaus A, Zuberi SM. Epileptic activity is a surrogate for an underlying etiology and stopping the activity has a limited
impact on developmental outcome. Epilepsia 2015;56:1477-81. DOI PubMed
13. Specchio N, Curatolo P. Developmental and epileptic encephalopathies: what we do and do not know. Brain 2021;144:32-43. DOI
PubMed
14. Steel D, Symonds JD, Zuberi SM, Brunklaus A. Dravet syndrome and its mimics: beyond SCN1A. Epilepsia 2017;58:1807-16. DOI
PubMed
15. Aledo-Serrano A, Mingorance A. [Analysis of the family impact and needs of Dravet's syndrome in Spain]. Rev Neurol 2020;70:75-
83. DOI PubMed
16. Brunklaus A, Zuberi SM. Dravet syndrome - from epileptic encephalopathy to channelopathy. Epilepsia 2014;55:979-84. DOI
PubMed
17. Riva A, Coppola A, Balagura G, et al. Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation. Epileptic
Disord 2021;23:397-401. DOI PubMed
18. Scheffer IE, Nabbout R. SCN1A-related phenotypes: epilepsy and beyond. Epilepsia 2019;60 Suppl 3:S17-24. DOI PubMed
19. Guerrini R, Balestrini S, Wirrell EC, Walker MC. Monogenic epilepsies: disease mechanisms, clinical phenotypes, and targeted